🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A study to evaluate the efficacy, safety and tolerability of Remibrutinib v...
Status
Recruiting
Location
Neuromuscular Research Center
Start Date
2025-02-07
Trial ID
NCT06744920
Treatments Being Tested
The purpose of this study was to evaluate the safety, tolerability and effi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-01-15
Trial ID
NCT05048342
Treatments Being Tested
The purpose of this Phase 3b study is to assess the efficacy, safety and to...
Status
Recruiting
Location
Perseverance Research Center
Start Date
2025-06-23
Trial ID
NCT06846281
Treatments Being Tested
The purpose of this study was to establish the efficacy, safety, and tolera...
Status
Completed
Location
Cahaba Derm and skin hlth ctr 27
Start Date
2021-12-01
Trial ID
NCT05032157
Treatments Being Tested
To compare the efficacy and safety of remibrutinib versus teriflunomide in ...
Status
Active Not Recruiting
Location
Ctr for Neurology and Spine
Start Date
2021-12-13
Trial ID
NCT05156281
Treatments Being Tested
The purpose of this study was to establish the efficacy, safety, and tolera...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-11-30
Trial ID
NCT05030311
Treatments Being Tested
The purpose of this study is to establish the efficacy, safety, and tolerab...
Status
Active Not Recruiting
Location
Total Skin and Beauty Dermatology Center PC
Start Date
2025-03-20
Trial ID
NCT06840392
Treatments Being Tested
The purpose of this trial is: 1. to assess the efficacy, pharmacokinetics,...
Status
Active Not Recruiting
Location
Kern Research
Start Date
2023-07-11
Trial ID
NCT05677451
Treatments Being Tested
This is a Phase 3, parallel group, placebo-controlled, double-blind, confir...
Status
Active Not Recruiting
Location
Allervie Clinical Research
Start Date
2023-12-07
Trial ID
NCT05976243
Treatments Being Tested
This is a US, multi-center, randomized, double-blind, double-dummy, Phase 3...
Status
Recruiting
Location
Allervie Clinical Research
Start Date
2025-07-11
Trial ID
NCT06868212
Treatments Being Tested